Geneva Pharmaceuticals Technology

Geneva Pharmaceuticals was a prominent American generic drug manufacturer that operated as a subsidiary of Novartis. The company specialized in the development, manufacturing, and marketing of a wide range of generic pharmaceutical products, including oral solids and injectable medications. In 2003, Novartis consolidated its global generics businesses under the Sandoz brand, leading to the retirement of the Geneva Pharmaceuticals name. During its peak, the company was a leader in the U.S. generic market, known for being among the first to launch generic versions of major blockbuster drugs. Today, its legacy and facilities continue to operate under the Sandoz organization.